Abbott Total Operating Expenses decreased by 1.1% to $9.21B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 1.6%, from $9.06B to $9.21B. Over 4 years (FY 2021 to FY 2025), Total Operating Expenses shows relatively stable performance with a 1.2% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Rising expenses without a corresponding rise in revenue can indicate operational bloat or aggressive expansion efforts.
The sum of all costs required to run the business that are not directly tied to production, including R&D and SG&A. It r...
Investors compare this to revenue to assess the 'operating leverage' of a business model.
is_total_operating_expenses| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $8.83B | $8.38B | $9.09B | $8.98B | $8.88B | $8.64B | $8.79B | $8.24B | $8.44B | $8.50B | $8.46B | $8.58B | $8.71B | $8.78B | $9.06B | $8.67B | $9.09B | $9.31B | $9.21B |
| QoQ Change | — | -5.1% | +8.4% | -1.2% | -1.1% | -2.7% | +1.7% | -6.2% | +2.4% | +0.7% | -0.4% | +1.4% | +1.5% | +0.8% | +3.3% | -4.4% | +4.9% | +2.4% | -1.1% |
| YoY Change | — | — | — | — | +0.6% | +3.1% | -3.3% | -8.3% | -5.0% | -1.7% | -3.7% | +4.1% | +3.2% | +3.3% | +7.1% | +1.0% | +4.4% | +6.1% | +1.6% |
We use cookies for analytics. See our Privacy and Cookie Policy.